Cargando…

How a disruption of the competition between HIF-1 and p53 for limiting p300/CBP by latent viruses can cause disease

Detalles Bibliográficos
Autores principales:	Polansky, Hanan, Schwab, Hava
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305108/ https://www.ncbi.nlm.nih.gov/pubmed/30603052 http://dx.doi.org/10.18632/genesandcancer.178

Ejemplares similares

Latent viruses can cause disease by disrupting the competition for the limiting factor p300/CBP
por: Polansky, Hanan, et al.
Publicado: (2018)

Copy number of latent viruses, oncogenicity, and the microcompetition model
por: Polansky, Hanan, et al.
Publicado: (2018)

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022)

Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015)

A Novel Function of Novobiocin: Disrupting the Interaction of HIF 1α and p300/CBP through Direct Binding to the HIF1α C-Terminal Activation Domain
por: Wu, Donglu, et al.
Publicado: (2013)

Curcumin, COX-2, and Protein p300/CBP
por: Jung, Ki Tae, et al.
Publicado: (2014)

Dimeric structure of p300/CBP associated factor
por: Shi, Shasha, et al.
Publicado: (2014)

Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016)

Genomic occupancy of the transcriptional co-activators p300 and CBP
por: Holmqvist, Per-Henrik, et al.
Publicado: (2013)

Epigenetic mechanisms to propagate histone acetylation by p300/CBP
por: Kikuchi, Masaki, et al.
Publicado: (2023)

Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53
por: Schuldner, Maximiliane, et al.
Publicado: (2019)

Is histone acetylation the most important physiological function for CBP and p300?
por: Bedford, David C., et al.
Publicado: (2012)

HBZ inhibits the HAT activity of the cellular coactivators p300 and CBP
por: Wright, Diana, et al.
Publicado: (2011)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014)

The prognostic capacities of CBP and p300 in locally advanced rectal cancer
por: Rühlmann, Felix, et al.
Publicado: (2019)

Loss of p300 and CBP disrupts histone acetylation at the mouse Sry promoter and causes XY gonadal sex reversal
por: Carré, Gwenn-Aël, et al.
Publicado: (2018)

AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300
por: Wang, Shengyu, et al.
Publicado: (2017)

A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer
por: Li, Hong-Mei, et al.
Publicado: (2020)

Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts
por: Chen, Guozhen, et al.
Publicado: (2009)

CBP / p300-mediated acetylation of histone H3 on lysine 56
por: Das, Chandrima, et al.
Publicado: (2009)

Genome-wide assessment of differential roles for p300 and CBP in transcription regulation
por: Ramos, Yolande F. M., et al.
Publicado: (2010)

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
por: Valor, Luis M, et al.
Publicado: (2013)

Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
por: Shirakawa, Kotaro, et al.
Publicado: (2016)

Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells
por: Bordonaro, Michael, et al.
Publicado: (2016)

Differential contribution of p300 and CBP to regulatory element acetylation in mESCs
por: Martire, Sara, et al.
Publicado: (2020)

Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation
por: Hlushchuk, Irena, et al.
Publicado: (2021)

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
por: Zhang, Xin, et al.
Publicado: (2020)

P300/CBP-Associated Factor Activates Cardiac Fibroblasts by SMAD2 Acetylation
por: Lim, Yongwoon, et al.
Publicado: (2021)

p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes
por: Martins, Vitor F., et al.
Publicado: (2022)

DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination
por: Akande, Oluwatoyin E., et al.
Publicado: (2019)

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
por: Strachowska, Magdalena, et al.
Publicado: (2021)

Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP
por: Tang, Yong, et al.
Publicado: (2008)

CBP/p300 and SIRT1 Are Involved in Transcriptional Regulation of S-Phase Specific Histone Genes
por: He, Hongpeng, et al.
Publicado: (2011)

CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis
por: Cazzalini, Ornella, et al.
Publicado: (2014)

Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain
por: Chaikuad, Apirat, et al.
Publicado: (2016)

Transcription Coactivators p300 and CBP Are Necessary for Photoreceptor-Specific Chromatin Organization and Gene Expression
por: Hennig, Anne K., et al.
Publicado: (2013)

Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases
por: Michaelides, Michael R., et al.
Publicado: (2017)

p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
por: Yao, Weilei, et al.
Publicado: (2018)

DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers
por: Li, Shanshan, et al.
Publicado: (2018)

CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells
por: Sauer, M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5uvgq6fq8uoqbm5tal0bi8t8ia